Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2020
Vaccination with Messenger RNA: A Promising Alternative to DNA VaccinationIstván Tombácz, Drew Weissman, Norbert Pardi
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interferenceJohn Capodici, Katalin Karikó, Drew Weissman
Current Topics in Microbiology and Immunology|April 18, 2020
Messenger RNA-Based Vaccines Against Infectious DiseasesMohamad-Gabriel Alameh, Drew Weissman, Norbert Pardi
Nature Reviews. Drug Discovery|August 26, 2021
mRNA vaccines for infectious diseases: principles, delivery and clinical translationNamit Chaudhary, Drew Weissman, Kathryn A Whitehead
Current Opinion in Immunology|April 4, 2020
Recent advances in mRNA vaccine technologyNorbert Pardi, Michael J Hogan, Drew Weissman
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 17, 2004
Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic toleranceKatalin Karikó, Drew Weissman, Frank A Welsh
European Journal of Immunology|April 17, 2008
Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccineJeremy B Wingard, Bart Anderson, Drew Weissman
Nature Reviews. Drug Discovery|September 22, 2021
Author Correction: mRNA vaccines for infectious diseases: principles, delivery and clinical translationNamit Chaudhary, Drew Weissman, Kathryn A Whitehead
Immunity|August 23, 2005
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNAKatalin Karikó, Michael Buckstein, Houping Ni, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
In vitro transcription of long RNA containing modified nucleosidesNorbert Pardi, Hiromi Muramatsu, Drew Weissman, et al.
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2020
Vaccination with Messenger RNA: A Promising Alternative to DNA VaccinationIstván Tombácz, Drew Weissman, Norbert Pardi
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interferenceJohn Capodici, Katalin Karikó, Drew Weissman
Current Topics in Microbiology and Immunology|April 18, 2020
Messenger RNA-Based Vaccines Against Infectious DiseasesMohamad-Gabriel Alameh, Drew Weissman, Norbert Pardi
Nature Reviews. Drug Discovery|August 26, 2021
mRNA vaccines for infectious diseases: principles, delivery and clinical translationNamit Chaudhary, Drew Weissman, Kathryn A Whitehead
Current Opinion in Immunology|April 4, 2020
Recent advances in mRNA vaccine technologyNorbert Pardi, Michael J Hogan, Drew Weissman
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 17, 2004
Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic toleranceKatalin Karikó, Drew Weissman, Frank A Welsh
European Journal of Immunology|April 17, 2008
Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccineJeremy B Wingard, Bart Anderson, Drew Weissman
Nature Reviews. Drug Discovery|September 22, 2021
Author Correction: mRNA vaccines for infectious diseases: principles, delivery and clinical translationNamit Chaudhary, Drew Weissman, Kathryn A Whitehead
Immunity|August 23, 2005
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNAKatalin Karikó, Michael Buckstein, Houping Ni, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
In vitro transcription of long RNA containing modified nucleosidesNorbert Pardi, Hiromi Muramatsu, Drew Weissman, et al.
Pageof 30